XTNT RSI Chart
Last 7 days
-9.9%
Last 30 days
-6.4%
Last 90 days
-31.1%
Trailing 12 Months
21.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 101.2M | 0 | 0 | 0 |
2023 | 63.0M | 67.9M | 78.5M | 91.3M |
2022 | 55.7M | 56.0M | 56.7M | 58.0M |
2021 | 51.1M | 55.5M | 55.3M | 55.3M |
2020 | 62.7M | 58.0M | 56.3M | 53.3M |
2019 | 71.0M | 67.5M | 66.0M | 64.7M |
2018 | 78.5M | 75.8M | 73.3M | 72.2M |
2017 | 91.1M | 91.1M | 87.8M | 82.6M |
2016 | 70.8M | 82.4M | 87.8M | 90.0M |
2015 | 35.9M | 36.9M | 46.2M | 59.3M |
2014 | 33.4M | 34.0M | 34.5M | 35.3M |
2013 | 33.8M | 33.9M | 32.9M | 33.1M |
2012 | 31.9M | 32.6M | 34.0M | 33.0M |
2011 | 19.1M | 22.8M | 26.5M | 30.1M |
2010 | 0 | 0 | 0 | 15.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 03, 2024 | brandt kevin d | acquired | - | - | 184,209 | chief commercial officer |
Apr 03, 2024 | neils scott c | acquired | - | - | 177,551 | chief financial officer |
Apr 03, 2024 | schallenberger mark a. | acquired | - | - | 177,551 | chief operations officer |
Apr 03, 2024 | browne sean e | acquired | - | - | 731,632 | president and ceo |
Jan 16, 2024 | neils scott c | sold (taxes) | -8,704 | 1.09 | -7,986 | chief financial officer |
Nov 17, 2023 | brandt kevin d | bought | 49,837 | 1.196 | 41,670 | chief commercial officer |
Oct 15, 2023 | browne sean e | sold (taxes) | -113,877 | 1.08 | -105,442 | president and ceo |
Oct 15, 2023 | browne sean e | sold (taxes) | -120,659 | 1.08 | -111,721 | president and ceo |
Aug 15, 2023 | bakewell john k | acquired | - | - | 145,180 | - |
Aug 15, 2023 | neils scott c | acquired | - | - | 116,144 | chief financial officer |
Which funds bought or sold XTNT recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | AWM Investment Company, Inc. | reduced | -19.3 | -87,107 | 442,501 | 0.06% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | added | 49.74 | 99,102 | 279,168 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | added | 9.33 | 8,931 | 76,580 | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | sold off | -100 | -37,489 | - | -% |
May 15, 2024 | Royal Bank of Canada | new | - | 1,000 | 1,000 | -% |
May 15, 2024 | ORBIMED ADVISORS LLC | unchanged | - | 2,924,580 | 85,544,100 | 1.57% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | unchanged | - | 14,740 | 431,145 | 0.01% |
May 15, 2024 | Nantahala Capital Management, LLC | reduced | -50.00 | -4,360,000 | 4,680,000 | 0.27% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -78.14 | -9,046 | 2,647 | -% |
May 15, 2024 | Altium Capital Management LP | reduced | -4.73 | -123,169 | 8,948,010 | 3.54% |
Unveiling Xtant Medical Holdings Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Xtant Medical Holdings Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Xtant Medical Holdings Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -0.8% | 27,873,000 | 28,108,500 | 25,019,000 | 20,232,000 | 17,943,000 | 15,270,500 | 14,462,000 | 15,277,000 | 12,959,000 | 13,969,500 | 13,777,000 | 14,975,000 | 12,542,000 | 14,014,500 | 14,016,000 | 10,529,000 | 14,778,000 | 16,964,000 | 15,721,000 | 15,271,000 | 16,726,000 |
Gross Profit | 1.0% | 17,302,000 | 17,137,500 | 15,334,000 | 12,459,000 | 10,536,000 | 8,306,500 | 7,896,000 | 8,374,000 | 7,560,000 | 7,694,000 | 7,191,000 | 9,515,000 | 8,091,000 | 8,982,000 | 9,248,000 | 6,550,000 | 9,613,000 | 11,398,500 | 10,411,000 | 9,906,000 | 10,813,000 |
Operating Expenses | -0.8% | 20,772,000 | 20,943,500 | 18,719,000 | 13,850,000 | 12,112,000 | 10,030,500 | 9,796,000 | 9,674,000 | 9,391,000 | 9,606,000 | 8,636,000 | 10,006,000 | 8,096,000 | 8,742,500 | 8,488,000 | 6,937,000 | 10,976,000 | 11,716,000 | 11,116,000 | 10,469,000 | 11,481,000 |
S&GA Expenses | 7.6% | 12,460,000 | 11,584,000 | 11,085,000 | 8,716,000 | 7,054,000 | 5,832,000 | 5,838,000 | 5,636,000 | 5,209,000 | 5,313,000 | 5,267,000 | 5,590,000 | 4,855,000 | 5,405,000 | 5,270,000 | 3,895,000 | 6,413,000 | 6,994,000 | 6,685,000 | 6,072,000 | 6,742,000 |
R&D Expenses | 7.1% | 527,000 | 492,000 | 490,000 | 180,000 | 174,000 | 232,000 | 229,000 | 241,000 | 213,000 | 151,000 | 262,000 | 243,000 | 214,000 | 126,500 | 176,000 | 111,000 | 245,000 | 257,000 | 203,000 | 210,000 | 262,000 |
EBITDA Margin | -36.0% | 0.04 | 0.06 | 0.07 | -0.07 | -0.08 | -0.09 | -0.10 | -0.09 | -0.08 | -0.05 | 0.00 | 0.04 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 2.1% | 835,000 | 817,500 | 760,000 | 786,000 | 575,000 | 495,500 | 440,000 | 397,000 | 359,000 | 466,000 | 329,000 | 199,000 | 1,000 | 717,500 | 2,097,000 | 2,054,000 | 1,108,000 | 1,268,000 | 1,185,000 | 1,301,000 | 2,018,000 |
Income Taxes | -88.2% | 68,000 | 577,000 | -2,300,000 | 13,000 | 13,000 | 20,500 | 13,000 | 13,000 | 23,000 | - | 30,000 | 43,000 | 23,000 | 228,000 | 23,000 | 23,000 | 22,000 | 30,000 | 23,000 | 22,000 | 23,000 |
Earnings Before Taxes | -16.3% | -4,332,000 | -3,726,000 | 6,931,000 | -2,177,000 | -2,065,000 | -2,188,500 | -2,340,000 | -1,697,000 | -2,190,000 | -2,378,000 | -1,774,000 | -690,000 | -6,000 | -478,000 | -1,337,000 | -2,441,000 | -2,471,000 | -1,574,500 | -1,856,000 | -1,917,000 | -2,776,000 |
EBT Margin | -187.4% | -0.03 | -0.01 | 0.01 | -0.13 | -0.13 | -0.15 | -0.15 | -0.14 | -0.13 | -0.09 | -0.05 | -0.05 | - | - | - | - | - | - | - | - | - |
Net Income | -2.3% | -4,400,000 | -4,303,000 | 9,231,000 | -2,190,000 | -2,078,000 | -2,209,000 | -2,353,000 | -1,710,000 | -2,213,000 | -2,283,000 | -1,804,000 | -733,000 | -29,000 | -706,000 | -1,360,000 | -2,464,000 | -2,493,000 | -1,604,500 | -1,879,000 | -1,939,000 | -2,799,000 |
Net Income Margin | -327.1% | -0.02 | 0.01 | 0.04 | -0.13 | -0.13 | -0.15 | -0.15 | -0.14 | -0.13 | -0.09 | -0.06 | -0.05 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -414.3% | -6,573,000 | -1,278,000 | -4,057,000 | -2,935,000 | -2,701,000 | -2,731,000 | -2,575,000 | -311,000 | -1,488,000 | -203,000 | -1,336,000 | 1,712,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 1.4% | 94.00 | 93.00 | 92.00 | 65.00 | 63.00 | 60.00 | 56.00 | 53.00 | 53.00 | 55.00 | 56.00 | 60.00 | 59.00 | 41.00 | 42.00 | 42.00 | 43.00 | 43.00 | 43.00 | 44.00 | 47.00 |
Current Assets | 2.6% | 67.00 | 65.00 | 64.00 | 40.00 | 37.00 | 49.00 | 45.00 | 42.00 | 43.00 | 44.00 | 46.00 | 49.00 | 48.00 | 31.00 | 32.00 | 31.00 | 32.00 | 32.00 | 32.00 | 32.00 | 34.00 |
Cash Equivalents | -20.4% | 5.00 | 6.00 | 9.00 | 4.00 | 5.00 | 20.00 | 17.00 | 16.00 | 17.00 | 18.00 | 18.00 | 20.00 | 19.00 | 2.00 | 3.00 | 3.00 | 3.00 | 5.00 | 6.00 | 7.00 | 7.00 |
Inventory | 5.0% | 39.00 | 37.00 | 34.00 | 20.00 | 19.00 | 17.00 | 17.00 | 16.00 | 17.00 | 18.00 | 20.00 | 21.00 | 22.00 | 21.00 | 21.00 | 20.00 | 18.00 | 16.00 | 16.00 | 16.00 | 17.00 |
Net PPE | 2.0% | 9.00 | 9.00 | 9.00 | 7.00 | 7.00 | 6.00 | 6.00 | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 5.00 | 6.00 | 6.00 |
Goodwill | 0% | 7.00 | 7.00 | 7.00 | 7.00 | 8.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
Liabilities | 12.1% | 46.00 | 41.00 | 37.00 | 34.00 | 31.00 | 26.00 | 23.00 | 25.00 | 24.00 | 24.00 | 23.00 | 26.00 | 25.00 | 27.00 | 90.00 | 89.00 | 89.00 | 87.00 | 86.00 | 86.00 | 86.00 |
Current Liabilities | 23.7% | 28.00 | 23.00 | 22.00 | 17.00 | 17.00 | 15.00 | 11.00 | 12.00 | 11.00 | 11.00 | 10.00 | 13.00 | 24.00 | 26.00 | 9.00 | 9.00 | 10.00 | 9.00 | 9.00 | 10.00 | 11.00 |
Long Term Debt | -2.0% | 17.00 | 17.00 | 14.00 | 16.00 | 12.00 | 10.00 | 11.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | - | - | 80.00 | 78.00 | 77.00 | 76.00 | 75.00 | 74.00 | 73.00 |
LT Debt, Current | - | - | - | 3.00 | 1.00 | 5.00 | 2.00 | 1.00 | - | - | - | - | - | 16.00 | 17.00 | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 17.00 | 14.00 | 16.00 | 12.00 | 10.00 | 11.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | - | - | 80.00 | 78.00 | 77.00 | 76.00 | 75.00 | 74.00 | 73.00 |
Shareholder's Equity | -7.1% | 48.00 | 51.00 | 55.00 | 31.00 | 33.00 | 34.00 | 33.00 | 28.00 | 29.00 | 31.00 | 33.00 | 34.00 | 33.00 | 15.00 | 48.00 | - | - | - | - | - | - |
Retained Earnings | -1.8% | -247 | -243 | -238 | -247 | -245 | -243 | -241 | -239 | -237 | -235 | -232 | -231 | -230 | -230 | -229 | -228 | -225 | -223 | -221 | -219 | -217 |
Additional Paid-In Capital | 0.3% | 295 | 294 | 294 | 279 | 278 | 278 | 274 | 267 | 267 | 266 | 266 | 265 | 264 | 245 | 182 | 181 | 179 | 179 | 179 | 179 | 179 |
Shares Outstanding | 0.0% | 130 | 130 | 130 | 109 | 109 | 109 | 89.00 | 87.00 | 87.00 | 87.00 | 87.00 | 87.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 26.00 | - | - | - | 7.00 | - | - | - | 22.00 | - | - | - | 4.00 | - | - | - | 12.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -533.9% | -5,800 | -915 | -3,834 | -2,521 | -2,245 | -2,288 | -2,064 | 15.00 | -1,004 | 423 | -926 | 2,249 | -1,307 | 916 | -71.00 | 213 | -1,789 | -71.00 | -1,296 | 464 | 490 |
Share Based Compensation | -3.0% | 910 | 938 | 745 | 439 | 617 | 639 | 641 | 571 | 613 | 708 | 580 | 465 | 456 | 358 | 237 | 220 | 269 | 259 | 95.00 | 39.00 | 122 |
Cashflow From Investing | 70.9% | -674 | -2,313 | -4,656 | -394 | -17,421 | -422 | -492 | -254 | -391 | -595 | -341 | -471 | -483 | -570 | -167 | -392 | -175 | -382 | -114 | 38.00 | -86.00 |
Cashflow From Financing | 1493.5% | 5,179 | 325 | 12,844 | 1,953 | 4,569 | 5,614 | 3,312 | 115 | -21.00 | -55.00 | -646 | 106 | 18,092 | -746 | -40.00 | -41.00 | -34.00 | -59.00 | -159 | -281 | -104 |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 27,873 | $ 17,943 |
Cost of sales | 10,571 | 7,407 |
Gross Profit | 17,302 | 10,536 |
Operating Expenses | ||
General and administrative | 7,785 | 4,884 |
Sales and marketing | 12,460 | 7,054 |
Research and development | 527 | 174 |
Total Operating Expenses | 20,772 | 12,112 |
Loss from Operations | (3,470) | (1,576) |
Other Expense | ||
Interest expense | (835) | (575) |
Interest income | 86 | |
Unrealized foreign currency translation loss | (39) | |
Other income | 12 | |
Total Other Expense | (862) | (489) |
Net Loss from Operations Before Provision for Income Taxes | (4,332) | (2,065) |
Provision for Income Taxes Current and Deferred | (68) | (13) |
Net Loss | $ (4,400) | $ (2,078) |
Net Loss Per Share: | ||
Basic | $ (0.03) | $ (0.02) |
Dilutive | $ (0.03) | $ (0.02) |
Shares used in the computation: | ||
Basic | 130,201,251 | 108,893,588 |
Dilutive | 130,201,251 | 108,893,588 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 4,547 | $ 5,715 |
Restricted cash | 77 | 208 |
Trade accounts receivable, net of allowance for credit losses and doubtful accounts of $954 and $920, respectively | 21,484 | 20,731 |
Inventories | 38,724 | 36,885 |
Prepaid and other current assets | 1,709 | 1,330 |
Total current assets | 66,541 | 64,869 |
Property and equipment, net | 8,867 | 8,692 |
Right-of-use asset, net | 1,437 | 1,523 |
Goodwill | 7,302 | 7,302 |
Intangible assets, net | 9,652 | 10,085 |
Other assets | 132 | 141 |
Total Assets | 93,931 | 92,612 |
Current Liabilities: | ||
Accounts payable | 7,378 | 7,054 |
Accrued liabilities | 9,875 | 10,419 |
Current portion of lease liability | 853 | 830 |
Current portion of finance lease obligations | 66 | 65 |
Line of credit | 10,270 | 4,622 |
Total current liabilities | 28,442 | 22,990 |
Long-term Liabilities: | ||
Lease liability, less current portion | 644 | 759 |
Finance lease obligation, less current portion | 99 | 116 |
Long-term debt, plus premium and less issuance costs | 16,826 | 17,167 |
Other liabilities | 240 | 231 |
Total Liabilities | 46,251 | 41,263 |
Commitments and Contingencies (note 14) | ||
Stockholders’ Equity: | ||
Preferred stock, $0.000001 par value; 10,000,000 shares authorized; no shares issued and outstanding | ||
Common stock, $0.000001 par value; 300,000,000 shares authorized; 130,216,541 shares issued and outstanding as of March 31, 2024 and 130,180,031 shares issued and outstanding as of December 31, 2023 | ||
Additional paid-in capital | 295,223 | 294,330 |
Accumulated other comprehensive (loss) income | (133) | 29 |
Accumulated deficit | (247,410) | (243,010) |
Total Stockholders’ Equity | 47,680 | 51,349 |
Total Liabilities & Stockholders’ Equity | $ 93,931 | $ 92,612 |